US FDA Inspections By The Numbers: Very Few During COVID

 
• By Michael McCaughan

GAO report offers new data on the impact of COVID on FDA’s drug inspections. (It was big.)

Cyber globe (sdecoret/Shutterstock.com)
• Source: Shutterstock

More from Manufacturing

More from Compliance